About Roivant Sciences Ltd.
Roivant Sciences Ltd. is a biopharmaceutical group. Its website says the company aims to get new medicines and health technologies to patients more quickly. Rather than running every program in-house, it forms separate subsidiaries, called Vants, which it describes as small, entrepreneurial biotech and healthcare technology businesses. The group was founded in 2014 and is the parent of more than a dozen subsidiaries, including Immunovant, a majority-owned public company focused on autoimmune diseases, and Dermavant Sciences, a privately held company focused on medical dermatology.
The company's clinical work spans several therapeutic areas. It reports 14 positive Phase 3 trials for its Vants since 2019 and cites two commercial launches: LISRAYA (brepocitinib) for adults with dermatomyositis in 2026, and VTAMA cream for plaque psoriasis in 2022. Its website lists a New York office at 1 Pennsylvania Plaza, which it says houses its clinical and corporate teams. Wikipedia describes New York City as its headquarters, with other major offices in Boston and Basel.
| Type | Organization |
|---|---|
| New York offices | New York City |
| Website | roivant.com |
| Registered NY attorneys | 7 |
Organization profile based on its official website and public sources (reviewed October 30, 2026). Attorney list from the New York State Unified Court System registration data. Not affiliated with Roivant Sciences Ltd..
Registered attorneys
Jo Chen Currently registered Lindsay Androski Currently registered Eric Wasserstrum Currently registered Samuel Kaplan Currently registered David Jakus Currently registered Michelle Mccarthy Currently registered Tanya Shaby Currently registeredRegistration status can change at any time. Confirm any attorney's current status through the official New York Attorney Search.